Related Experiment Video
Updated: Jul 2, 2025

05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.3K
Bright Light Therapy for Major Depressive Disorder in Adolescent Outpatients: A Preliminary Study
Rachel Ballard1, John T Parkhurst1, Lisa K Gadek2
1Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Ave., Box 10, Chicago, IL 60611, USA.
Clocks & Sleep
|February 23, 2024
Summary
Bright light therapy (BLT) is a feasible and acceptable treatment for adolescent depression in outpatient settings. This study showed significant improvements in mood and sleep, supporting further research in primary care.
Area of Science:
- Psychiatry
- Adolescent Health
- Chronobiology
Background:
- Bright light therapy (BLT) is understudied in adolescents with major depressive disorder, especially in outpatient settings.
- Adolescent depression requires accessible and effective treatment options.
Purpose of the Study:
- To evaluate the feasibility, acceptability, and efficacy of BLT for adolescents with moderate to severe depression in a primary care setting.
- To assess the impact of BLT on mood and sleep patterns in this population.
Main Methods:
- An 8-week clinical trial involving adolescents recruited from a primary care practice.
- Assessed feasibility and acceptability through daily light box use and routine integration.
- Measured treatment effects using the Short Mood and Feelings Questionnaire (SMFQ) and actigraphic sleep variables.
Main Results:
- High adherence rates were observed, with participants integrating midday BLT more easily than morning sessions.
- Significant improvements in depression scores were noted during the BLT phase.
- Sleep efficiency increased significantly, with a trend towards decreased sleep onset latency.
Conclusions:
- Self-administered home-based BLT is a feasible, acceptable, and effective treatment for adolescent outpatients with depression.
- Findings support further large-scale, controlled clinical trials of BLT in primary care settings.
Related Concept Videos
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
Antidepressant Drugs: MAOIs and Other Agents
230
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
230
Management of Insomnia
248
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
248

